Intervention

Cabergoline

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 5 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials5

Recruiting0

Common conditions14

Lead sponsors shown5

Clinical trials

5 shown

Co-administration of Cabergoline and Gliclazide Improve Glycemic Parameters and Lipid Profile in T2DM PatientsNCT03313661 · 2017-10-14

UNKNOWN

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored StudiesNCT01794793 · 2013-06-10

COMPLETED

Cabergoline Effect on Blood Sugar in Type 2 DiabeticsNCT01459601 · 2012-01-01

UNKNOWN

Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's DiseaseNCT00153972 · 2005-02-01

COMPLETED

Effect of Cabergoline on Weight and Glucose ToleranceNCT01395602 · 2002-04-01

COMPLETED

Common conditions

Acromegaly1 Body Weight1 Cushing's Disease1 Diabetes1 Diabetes Type 21 Dumping Syndrome1 Ectopic ACTH Secreting (EAS) Tumors1 Impaired Glucose Tolerance in Obese1 Melanoma Negative for bRAF1 Melanoma Negative for nRAS1 Neuroendocrine Tumors1 Parkinson's Disease1 Pituitary Tumors1 Prostate Cancer1

Leading sponsors

Columbia University 1 Mashhad University of Medical Sciences 1 RECORDATI GROUP 1 Sherief Abd-Elsalam 1 Technische Universität Dresden 1

Trial status mix

COMPLETED3

UNKNOWN2

Phase mix

PHASE42

NA1

PHASE11

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.